Carbamylated Hemoglobin as a Therapeutic Marker in Hemodialysis

Publisher： Karger

E-ISSN： 2235-3186|91|2|228-234

ISSN： 1660-8151

Source： Nephron, Vol.91, Iss.2, 2002-06, pp. : 228-234

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hospitalization and Mortality in Hemodialysis Patients: Association with Hemoglobin Variability

By  

Blood Purification, Vol. 35, Iss. 4, 2013-05 ,pp. : 247-257

Karger

Access to resources Recommend Favorite

Skin Autofluorescence: A Pronounced Marker of Mortality in Hemodialysis Patients

By  

Nephron Extra, Vol. 2, Iss. 1, 2012-07 ,pp. : 184-191

Karger

Access to resources Recommend Favorite

Implications of a Reduction in the Hemoglobin Target in Erythropoiesis-Stimulating Agent-Treated Hemodialysis Patients

By  

Nephron Extra, Vol. 1, Iss. 1, 2011-11 ,pp. : 212-216

Karger

Access to resources Recommend Favorite

Comment on the Paper: Hospitalization and Mortality in Hemodialysis Patients: Association with Hemoglobin Variability

By  

Blood Purification, Vol. 37, Iss. 1, 2014-02 ,pp. : 47-47

Karger

Access to resources Recommend Favorite

Hemoglobin Level Is an Important Determinant of Acid-Base Status in Hemodialysis Patients

By  

Nephron, Vol. 90, Iss. 1, 2001-12 ,pp. : 111-113

Karger

Access to resources Recommend Favorite